Health & Life CoROCO:1781 +1.69%48 Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus rates ROCO:1781 with a GF Score™ of 48/100 and a GF Value™ of NT$8.75 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Health & Life Co ranks worse than 318471.02% on this metric.
As of today (2026-07-06), the Forward Annual Dividend Yield of Health & Life Co is 0.00%.
As of today (2026-07-06), the Trailing Annual Dividend Yield of Health & Life Co is 0.00%.
ROCO:1781's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.085 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Health & Life Co (ROCO:1781) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Health & Life Co Forward Dividend Yield % Related Terms
ROCO:1781 vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, Health & Life Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health & Life Co Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Health & Life Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Health & Life Co's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Health & Life Co (ROCO:1781) has a Forward Dividend Yield % of 0.00% as of Jul. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Health & Life Co and its competitors. According to the industry distribution chart, Health & Life Co ranks #999999 out of 314 companies in the Medical Devices & Instruments industry.
Is Health & Life Co's Forward Dividend Yield % too high?
Health & Life Co's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Health & Life Co ranks #999999 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Health & Life Co has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Health & Life Co's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Health & Life Co ranks #999999 out of 314 companies for Forward Dividend Yield %. This places Health & Life Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Health & Life Co and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health & Life Co's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health & Life Co stock overvalued right now?
Based on GuruFocus' analysis, Health & Life Co (ROCO:1781) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$8.75, compared to a current price of NT$12.05 — trading 37.7% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. Health & Life Co's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Health & Life Co (ROCO:1781), the current Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health & Life Co (ROCO:1781) Overvalued in 2026?
Based on GuruFocus' analysis, Health & Life Co stock appears to be overvalued.
The current stock price of NT$12.05 is trading 37.7% above its estimated GF Value™ of NT$8.75.
GuruFocus considers Health & Life Co to be Significantly Overvalued.
Key valuation signals for ROCO:1781:
Forward Dividend Yield %: 0.00%
GF Value™: NT$8.75 vs. price of NT$12.05 (37.7% above fair value)
No single metric tells the full story. See the ROCO:1781 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health & Life Co Ltd manufactures medical devices in the fields of cardiovascular disease and in-vitro diagnostics in Taiwan. Its product portfolio includes blood pressure monitor series, nebulizer, and blood glucose monitoring system, blood glucose stripes and Thermometer.
48GF Score
Get the complete analysis for ROCO:1781
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1781 has been successfully added to your 